Literature DB >> 2642576

Clinicopathologic manifestations and breakpoints of the t(3;5) in patients with acute nonlymphocytic leukemia.

S C Raimondi1, I D Dubé, M B Valentine, J Mirro, H J Watt, R A Larson, M A Bitter, M M Le Beau, J D Rowley.   

Abstract

Acquired chromosomal rearrangements in acute nonlymphocytic leukemia (ANLL) have been linked to specific clinicopathologic features that suggest new disease subtypes. In this collaborative study, we report five patients with ANLL and a t(3;5) in their leukemic cells. At diagnosis, four of the patients had a t(3;5) as their sole karyotypic anomaly; the remaining patient had additional structural and numerical abnormalities. Careful cytogenetic analysis indicated that the breakpoints of this rearrangement are 3q25.1 and 5q34, in contrast to the various breakpoints reported in earlier studies (3q21----3q25 and 5q31----5q35). The karyotypic, morphologic, and clinical characteristics of this group, as well as those of 14 previously reported patients with the t(3;5), were compared to identify any features that might warrant consideration of a specific syndrome. The available information indicates a worldwide distribution and a nearly equal male:female ratio for patients with this translocation. The median age of the group, 37 years, was younger than that of all patients with ANLL, 49 years. A preceding myelodysplastic syndrome was observed in three patients. The limited numbers of observations on leukocyte count, hemoglobin level, and platelet count precluded meaningful comparison with data for ANLL patients in general. Although each FAB morphologic subtype, except M3, occurred in patients with a t(3;5), the frequency of M6 was much greater than expected. Bone marrows from each of the five patients we report showed increased numbers of megakaryocytes; trilineage dysplasia was observed in the marrow of each of the four patients for whom it could be assessed. Taken together, these findings suggest that the t(3;5) may affect cells capable of differentiation into multiple lineages.

Entities:  

Mesh:

Year:  1989        PMID: 2642576

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  14 in total

1.  Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26.

Authors:  K Morishita; E Parganas; C L William; M H Whittaker; H Drabkin; J Oval; R Taetle; M B Valentine; J N Ihle
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

2.  Acute myeloid leukemia with translocation t(3;5): new molecular insights.

Authors:  Florent Dumézy; Aline Renneville; Caroline Mayeur-Rousse; Olivier Nibourel; Elise Labis; Claude Preudhomme
Journal:  Haematologica       Date:  2013-02-12       Impact factor: 9.941

3.  cDNA cloning, expression pattern, and chromosomal localization of Mlf1, murine homologue of a gene involved in myelodysplasia and acute myeloid leukemia.

Authors:  J K Hitzler; D P Witte; N A Jenkins; N G Copeland; D J Gilbert; C W Naeve; A T Look; S W Morris
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

4.  Myeloid leukemia factor 1 regulates p53 by suppressing COP1 via COP9 signalosome subunit 3.

Authors:  Noriko Yoneda-Kato; Kiichiro Tomoda; Mari Umehara; Yukinobu Arata; Jun-ya Kato
Journal:  EMBO J       Date:  2005-04-21       Impact factor: 11.598

5.  Retroviral insertions 90 kilobases proximal to the Evi-1 myeloid transforming gene activate transcription from the normal promoter.

Authors:  C Bartholomew; J N Ihle
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

6.  Shuttling imbalance of MLF1 results in p53 instability and increases susceptibility to oncogenic transformation.

Authors:  Noriko Yoneda-Kato; Jun-Ya Kato
Journal:  Mol Cell Biol       Date:  2007-10-29       Impact factor: 4.272

7.  Myeloid leukemia factor 1 interfered with Bcl-XL to promote apoptosis and its function was regulated by 14-3-3.

Authors:  Yi Sun; Amina Fu; Wu Xu; Jyh-Rong Chao; Simon Moshiach; Stephan W Morris
Journal:  J Physiol Biochem       Date:  2015-11-12       Impact factor: 4.158

8.  Subtype-specific patterns of molecular mutations in acute myeloid leukemia.

Authors:  D Rose; T Haferlach; S Schnittger; K Perglerová; W Kern; C Haferlach
Journal:  Leukemia       Date:  2016-06-10       Impact factor: 11.528

9.  Cytogenetics findings in a histiocytic sarcoma case.

Authors:  J M Alonso-Dominguez; M Calbacho; M Talavera; C Villalon; L Abalo; J V Garcia-Gutierrez; S Lozano; M Tenorio; J Villarrubia; J Lopez-Jimenez; M T Ferro
Journal:  Case Rep Hematol       Date:  2012-06-03

Review 10.  Cytogenetics of Pediatric Acute Myeloid Leukemia: A Review of the Current Knowledge.

Authors:  Julie Quessada; Wendy Cuccuini; Paul Saultier; Marie Loosveld; Christine J Harrison; Marina Lafage-Pochitaloff
Journal:  Genes (Basel)       Date:  2021-06-17       Impact factor: 4.141

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.